Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from DENTSPLY SIRONA ( (XRAY) ).
On June 12, 2025, DENTSPLY SIRONA Inc. issued $550 million in Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055, with an interest rate of 8.375% per year until 2030, and thereafter adjusted based on the Five-year U.S. Treasury Rate plus a spread, ensuring it does not fall below the initial rate. The proceeds from this issuance were partially used to repay and terminate the company’s $435 million Bridge Loan Facility, resulting in no early termination penalties or prepayment premiums, which may positively impact the company’s financial stability and operational flexibility.
The most recent analyst rating on (XRAY) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score reflects significant financial performance challenges, with declining revenues and negative margins impacting the score. Technical analysis suggests some stabilization, while the earnings call highlighted both operational strengths and market challenges. Valuation remains a concern with a negative P/E ratio, although the dividend yield is a positive factor for some investors.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing a wide range of dental products and technologies, including dental equipment and consumables. The company focuses on innovation and quality in dental care, serving dental professionals and healthcare providers globally.
Average Trading Volume: 3,158,862
Technical Sentiment Signal: Sell
Current Market Cap: $3.27B
For a thorough assessment of XRAY stock, go to TipRanks’ Stock Analysis page.